• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浆液性和子宫内膜样子宫癌患者的危险因素及激素水平

Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.

作者信息

Sherman M E, Sturgeon S, Brinton L A, Potischman N, Kurman R J, Berman M L, Mortel R, Twiggs L B, Barrett R J, Wilbanks G D

机构信息

Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

出版信息

Mod Pathol. 1997 Oct;10(10):963-8.

PMID:9346174
Abstract

We performed a multi-institutional, incident case-control study of 328 endometrioid and 26 serous carcinomas to assess whether risk factors and circulating hormone levels in women with serous carcinoma differ from the expected profile for endometrial carcinoma We also evaluated exposures potentially related to endometrial cancer risk, anthropometric measurements, and circulating levels of sex hormones and related carrier proteins. Histopathologic specimens were reviewed without knowledge of the other data. As expected, a statistically significant association was observed for high body mass index (BMI) (relative risk, 3.5) and use of menopausal estrogens (relative risk, 2.4) in the endometrioid carcinoma cases, whereas serous carcinomas were not strongly associated with these factors. Smoking and oral contraceptive use decreased risk for both tumor types. For five of six sex hormones tested, age-adjusted mean serum levels in patients with serous carcinoma were significantly lower than those in women with endometrioid carcinoma. After adjustment for BMI, these differences were narrowed, but levels of albumin-bound estradiol and estrone remained significantly lower in the serous cases. Age and BMI-adjusted levels of sex hormone-binding globulin were significantly higher in patients with serous carcinoma than in women with endometrioid carcinomas. In conclusion, risk factors and sex hormone levels in patients with uterine serous carcinoma seem to differ from those in women with endometrioid carcinoma, suggesting that there may be at least two different pathways of endometrial carcinogenesis.

摘要

我们开展了一项多机构的病例对照研究,纳入328例子宫内膜样癌和26例浆液性癌患者,以评估浆液性癌女性患者的危险因素和循环激素水平是否与子宫内膜癌的预期特征不同。我们还评估了可能与子宫内膜癌风险相关的暴露因素、人体测量指标以及性激素和相关载体蛋白的循环水平。在不知晓其他数据的情况下对组织病理学标本进行了复查。正如预期的那样,在子宫内膜样癌病例中,观察到高体重指数(BMI)(相对风险为3.5)和使用绝经后雌激素(相对风险为2.4)之间存在统计学显著关联,而浆液性癌与这些因素的关联并不强烈。吸烟和使用口服避孕药会降低这两种肿瘤类型的发病风险。在所检测的六种性激素中的五种中,浆液性癌患者经年龄调整后的平均血清水平显著低于子宫内膜样癌女性患者。在对BMI进行调整后,这些差异有所缩小,但浆液性癌病例中白蛋白结合雌二醇和雌酮的水平仍然显著较低。浆液性癌患者经年龄和BMI调整后的性激素结合球蛋白水平显著高于子宫内膜样癌女性患者。总之,子宫浆液性癌患者的危险因素和性激素水平似乎与子宫内膜样癌女性患者不同,这表明子宫内膜癌的发生可能至少存在两种不同途径。

相似文献

1
Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.浆液性和子宫内膜样子宫癌患者的危险因素及激素水平
Mod Pathol. 1997 Oct;10(10):963-8.
2
Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.人激肽释放酶6:子宫浆液性乳头状癌一种新的潜在血清生物标志物。
Clin Cancer Res. 2005 May 1;11(9):3320-5. doi: 10.1158/1078-0432.CCR-04-2528.
3
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.激肽释放酶10(hK10)在子宫浆液性乳头状癌中的过表达。
Am J Obstet Gynecol. 2006 May;194(5):1296-302. doi: 10.1016/j.ajog.2005.10.794. Epub 2006 Apr 21.
4
Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.子宫内膜样子宫癌的组织病理学特征及流行病学危险因素分析
Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):231-5.
5
Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.子宫乳头状浆液性癌:后续或同时发生乳腺癌的风险增加。
Gynecol Oncol. 2001 Dec;83(3):501-3. doi: 10.1006/gyno.2001.6445.
6
Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.绝经状态、高血压和肥胖作为子宫内膜息肉恶变的危险因素。
Maturitas. 2007 Feb 20;56(2):190-7. doi: 10.1016/j.maturitas.2006.08.002. Epub 2006 Sep 11.
7
Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.与高危型子宫内膜上皮癌相比,子宫内膜癌肉瘤具有不同的预后和扩散模式。
Gynecol Oncol. 2005 Aug;98(2):274-80. doi: 10.1016/j.ygyno.2005.04.027.
8
Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.同时累及子宫和输卵管的子宫内膜样癌:13例临床病理研究
Am J Surg Pathol. 2006 Jul;30(7):844-9. doi: 10.1097/01.pas.0000209839.00467.05.
9
High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.子宫内膜癌患者血清白细胞介素-6水平升高与子宫浆液性乳头状组织学有关,后者是一种侵袭性很强且对化疗耐药的子宫内膜癌变体。
Gynecol Oncol. 2005 Jul;98(1):92-8. doi: 10.1016/j.ygyno.2005.03.016.
10
Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.β-连环蛋白和E-钙黏蛋白在高级别子宫内膜癌中的表达模式与组织学亚型相关。
Mod Pathol. 2002 Oct;15(10):1032-7. doi: 10.1097/01.MP.0000028573.34289.04.

引用本文的文献

1
Comparison of clinical characteristics and prognosis between type I and type II endometrial cancer: a single-center retrospective study.I型与II型子宫内膜癌的临床特征及预后比较:一项单中心回顾性研究。
Discov Oncol. 2023 Nov 23;14(1):211. doi: 10.1007/s12672-023-00820-1.
2
Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.与识别具有内分泌干扰特性的物质相关的不良结局途径的发展 子宫腺癌作为不良结局
EFSA J. 2023 Feb 14;21(2):e07744. doi: 10.2903/j.efsa.2023.7744. eCollection 2023 Feb.
3
Racial and ethnic differences in type II endometrial cancer mortality outcomes: The contribution of sociodemographic, clinicopathologic, and treatment factors.
种族和民族差异对 II 型子宫内膜癌死亡率的影响:社会人口学、临床病理学和治疗因素的作用。
Gynecol Oncol. 2023 Jan;168:119-126. doi: 10.1016/j.ygyno.2022.11.015. Epub 2022 Nov 23.
4
Outdoor light at night and risk of endometrial cancer in the NIH-AARP diet and health study.夜间室外光与 NIH-AARP 饮食与健康研究中子宫内膜癌的风险。
Cancer Causes Control. 2023 Feb;34(2):181-187. doi: 10.1007/s10552-022-01632-4. Epub 2022 Oct 12.
5
EZH2 and Endometrial Cancer Development: Insights from a Mouse Model.EZH2 与子宫内膜癌的发生发展:来自于小鼠模型的研究进展。
Cells. 2022 Mar 7;11(5):909. doi: 10.3390/cells11050909.
6
The histological type of endometrial cancer is not associated with menopause status at diagnosis.子宫内膜癌的组织学类型与诊断时的绝经状态无关。
Biosci Rep. 2022 Mar 31;42(3). doi: 10.1042/BSR20212192.
7
Tailored Therapy Based on Molecular Characteristics in Endometrial Cancer.基于子宫内膜癌分子特征的个体化治疗。
Biomed Res Int. 2021 May 5;2021:2068023. doi: 10.1155/2021/2068023. eCollection 2021.
8
Genetic Susceptibility to Endometrial Cancer: Risk Factors and Clinical Management.子宫内膜癌的遗传易感性:风险因素与临床管理
Cancers (Basel). 2020 Aug 25;12(9):2407. doi: 10.3390/cancers12092407.
9
Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies.子宫内膜癌作为一种代谢疾病,其特征是 PI3K 信号失调:揭示新的治疗策略。
Int J Mol Sci. 2020 Aug 23;21(17):6073. doi: 10.3390/ijms21176073.
10
Review of immunohistochemical typing of endometrial carcinoma at the Lagos University Teaching Hospital.拉各斯大学教学医院子宫内膜癌免疫组化分型综述。
Afr Health Sci. 2019 Sep;19(3):2468-2475. doi: 10.4314/ahs.v19i3.22.